Articles with "transthyretin amyloid" as a keyword



Photo by pattib from unsplash

Patterns of myelinated nerve fibers loss in transthyretin amyloid polyneuropathy and mimics

Sign Up to like & get
recommendations!
Published in 2022 at "Annals of Clinical and Translational Neurology"

DOI: 10.1002/acn3.51599

Abstract: The present study was intended to analyze the characteristics of myelinated nerve fibers density (MFD) of transthyretin amyloid polyneuropathy (ATTR‐PN) and other similar neuropathies. read more here.

Keywords: transthyretin amyloid; nerve fibers; amyloid polyneuropathy; myelinated nerve ... See more keywords
Photo from wikipedia

A simple staging system using biomarkers for wild‐type transthyretin amyloid cardiomyopathy in Japan

Sign Up to like & get
recommendations!
Published in 2022 at "ESC Heart Failure"

DOI: 10.1002/ehf2.13847

Abstract: It has been reported that a staging system combining N‐terminal pro‐B‐type natriuretic peptide and high‐sensitivity troponin T (hs‐cTnT) or estimated glomerular filtration rate (eGFR) is useful in patients with wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM). However,… read more here.

Keywords: system; staging system; type transthyretin; amyloid cardiomyopathy ... See more keywords
Photo by stayandroam from unsplash

Suspicion, screening, and diagnosis of wild‐type transthyretin amyloid cardiomyopathy: a systematic literature review

Sign Up to like & get
recommendations!
Published in 2022 at "ESC Heart Failure"

DOI: 10.1002/ehf2.13884

Abstract: Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt CM) is a more common disease than previously thought. Awareness of ATTRwt CM and its diagnosis has been challenged by its unspecific and widely distributed clinical manifestations and traditionally invasive… read more here.

Keywords: amyloid cardiomyopathy; type transthyretin; transthyretin amyloid; diagnosis ... See more keywords
Photo by jannerboy62 from unsplash

Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis

Sign Up to like & get
recommendations!
Published in 2022 at "ESC Heart Failure"

DOI: 10.1002/ehf2.13909

Abstract: To clarify the usefulness of left atrial (LA) function and left ventricular (LV) function obtained by two‐dimensional (2D) speckle tracking echocardiography to diagnose concomitant transthyretin amyloid cardiomyopathy (ATTR‐CM) in patients with aortic stenosis (AS). read more here.

Keywords: amyloid cardiomyopathy; left atrial; transthyretin amyloid; aortic stenosis ... See more keywords

Prevalence, characteristics, and mortality of patients with transthyretin amyloid cardiomyopathy in the Nordic countries

Sign Up to like & get
recommendations!
Published in 2022 at "ESC Heart Failure"

DOI: 10.1002/ehf2.13961

Abstract: Transthyretin amyloid cardiomyopathy (ATTR‐CM) is a progressive condition caused by deposition of transthyretin amyloid fibrils in the heart and is associated with poor quality of life and a shortened lifespan. This study aimed to describe… read more here.

Keywords: amyloid cardiomyopathy; transthyretin amyloid; prevalence; mortality patients ... See more keywords
Photo from wikipedia

SGLT2 inhibitor therapy for transthyretin amyloid cardiomyopathy: early tolerance and clinical response to dapagliflozin

Sign Up to like & get
recommendations!
Published in 2022 at "ESC Heart Failure"

DOI: 10.1002/ehf2.14188

Abstract: Sodium‐glucose cotransporter 2 inhibitors (SGLT2i) improve clinical outcomes in heart failure patients with reduced and preserved left ventricular ejection fraction (LVEF), but have not yet been investigated in transthyretin amyloid cardiomyopathy (ATTR‐CM). This study aimed… read more here.

Keywords: amyloid cardiomyopathy; inhibitor therapy; transthyretin amyloid; sglt2 inhibitor ... See more keywords
Photo by peterconlan from unsplash

Health‐related quality of life among transthyretin amyloid cardiomyopathy patients

Sign Up to like & get
recommendations!
Published in 2023 at "ESC Heart Failure"

DOI: 10.1002/ehf2.14350

Abstract: Transthyretin amyloid cardiomyopathy (ATTR CM) is a progressive and severe heart disease with physical and psychological implications. The Nordic PROACT study was conducted to investigate the health‐related quality of life (HRQoL) in ATTR CM patients. read more here.

Keywords: amyloid cardiomyopathy; transthyretin amyloid; quality life; related quality ... See more keywords

CARE TRAJECTORY AND EARLY CLINICAL FEATURES AMONG PATIENTS WITH 99MTC-PYROPHOSPHATE POSITIVE TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM)

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of the American College of Cardiology"

DOI: 10.1016/s0735-1097(20)31447-9

Abstract: Transthyretin amyloid cardiomyopathy (ATTR-CM) may be more common than previously thought and is often underdiagnosed. We sought to evaluate traditionally accepted “red flag” clinical features with novel methods. We identified a random sample of 46… read more here.

Keywords: cardiomyopathy attr; amyloid cardiomyopathy; transthyretin amyloid; clinical features ... See more keywords

Clinical, electrocardiographic, and echocardiographic parameters associated with the development of pacing and implantable cardioverter-defibrillator indication in patients with transthyretin amyloid cardiomyopathy

Sign Up to like & get
recommendations!
Published in 2023 at "Europace"

DOI: 10.1093/europace/euad105

Abstract: Abstract Aims This study aimed to identify factors for attention leading to future pacing device implantation (PDI) and reveal the necessity of prophylactic PDI or implantable cardioverter-defibrillator (ICD) implantation in transthyretin amyloid cardiomyopathy (ATTR-CM) patients.… read more here.

Keywords: attrv; transthyretin amyloid; pdi; block ... See more keywords
Photo by solenfeyissa from unsplash

Transthyretin amyloid deposits in lumbar spinal stenosis and assessment of signs of systemic amyloidosis

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Internal Medicine"

DOI: 10.1111/joim.13222

Abstract: Wild‐type transthyretin (ATTRwt) amyloidosis is the most common systemic amyloidosis in Western countries and manifests mainly as progressive restrictive cardiomyopathy. read more here.

Keywords: amyloid deposits; amyloidosis; systemic amyloidosis; deposits lumbar ... See more keywords
Photo from wikipedia

Tafamidis for the Treatment of Hereditary Transthyretin Amyloid Cardiomyopathy: A Case Report

Sign Up to like & get
recommendations!
Published in 2017 at "Cardiology"

DOI: 10.1159/000455089

Abstract: Tafamidis meglumine is a novel medicine that has been shown to slow the progression of peripheral neurological impairment in patients with hereditary transthyretin amyloidosis (ATTR). However, the efficacy of tafamidis against ATTR-related cardiac amyloidosis remains… read more here.

Keywords: tafamidis treatment; amyloid cardiomyopathy; treatment; case ... See more keywords